The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNationwide Ccds Regulatory News (NBS)

Share Price Information for Nationwide Ccds (NBS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 133.00
Bid: 130.00
Ask: 136.00
Change: 0.00 (0.00%)
Spread: 6.00 (4.615%)
Open: 133.00
High: 133.00
Low: 133.00
Prev. Close: 133.00
NBS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Response to Results of BoE Stress Test 2022

12 Jul 2023 07:30

RNS Number : 6938F
Nationwide Building Society
12 July 2023
 

Nationwide Building Society ("Nationwide")

Embargoed to 7.30am on 12 July 2023

NATIONWIDE'S RESPONSE TO THE RESULTS OF THE BANK OF ENGLAND STRESS TEST 2022

 

Today the Bank of England issued the results of its latest Concurrent Stress Test. The specified hypothetical Annual Cyclical Scenario (ACS) 2022 considered a 31% fall in house prices, 8.5% peak in unemployment and Bank Base Rate peak of 6% in the first year of the scenario.

 

The results of ACS 2022 confirm that Nationwide would remain profitable in such conditions and continue to make full distributions on all Tier 1 capital instruments, with a minimum stressed CET1 ratio of 20.4%, and a minimum UK leverage ratio of 5.6%, after the application of management actions. In each case the Society remains substantially above the regulatory hurdle rates set for this stress test of 7.4% CET1 ratio and 3.6% UK leverage ratio, both before and after the application of management actions.

 

The PRA has confirmed that Nationwide is not required to submit a revised capital plan or take additional actions as a result of this stress test exercise.

 

As in the stress testing exercises completed in previous years, the CET1 ratio reduces primarily due to the impact of the significant house price reduction, rising interest rate environment and increase in unemployment rate on model risk weights, rather than capital losses.

 

The CST 2022 exercise was modelled using currently approved mortgage models with the June 2022 start point reflecting a temporary model adjustment applied to risk weighted assets to ensure outcomes are consistent with the PRA's revised IRB regulations which became effective on 1 January 2022 (for more information see Nationwide Pillar 3 disclosures). These regulations aim to increase consistency of approaches across different firms and reduce volatility of mortgage risk weights across differing economic conditions. As expected, this has significantly reduced the extent to which risk weighted assets (RWA) increase in ACS 2022 given the higher RWA start point.

 

Nationwide recognises the value of industry-wide stress testing and continues to support the financial stability objectives of the Financial Policy Committee and the Bank of England.

 

On 19 May, Nationwide issued its full-year results for the period 5 April 2022 to 4 April 2023. These results reflected the continued capital strength and security of the business with a CET1 ratio of 26.5% (4 April 2022: 24.1%) and leverage ratio of 6.0% (4 April 2022: 5.4%).

 

Contacts:

Media Queries:

Sara Batchelor

Media Relations

T: +44 (0)7785 344 137

Sara.Batchelor@nationwide.co.uk

 

Investor Queries:

Sarah Abercrombie

Head of Investor Relations, Credit Ratings and Treasury Sustainability

T: +44 (0)7587 886 500

Sarah.Abercrombie@nationwide.co.uk

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RSPGPUAWMUPWGCG
Date   Source Headline
17th Nov 20177:00 amRNSNationwide Building Society - Interim Results 2017
2nd Nov 20173:15 pmRNSOutcome of Audit Tender
16th Oct 20174:09 pmRNSPublication of Final Terms
14th Sep 20171:45 pmRNSDTR 5 Announcement
14th Sep 20178:41 amRNSAdmission to trading on the London Stock Exchange
12th Sep 20175:18 pmRNSStabilisation Notice
12th Sep 20177:00 amRNSPublication of a Prospectus
7th Sep 20172:02 pmRNSIssue of CCDS
7th Sep 20179:34 amRNSStabilisation Notice
6th Sep 20179:49 amRNSIssue of CCDS
31st Aug 20175:43 pmRNSPublication of a Prospectus
11th Aug 20176:31 pmRNSPublication of Suppl.Prospcts (Replacement)
11th Aug 20175:25 pmRNSPublication of Suppl.Prospcts
11th Aug 20177:00 amRNSInterim Management Statement
26th Jul 20179:50 amRNSRedemption of Callable Reset Subordinated Notes
24th Jul 201710:14 amRNSPublication of Final Terms
20th Jul 20173:23 pmRNSResult of AGM
18th Jul 20172:39 pmRNSStabilisation Notice - Nationwide
18th Jul 20172:36 pmRNSStabilisation Notice - Nationwide
18th Jul 20178:27 amRNSStabilisation Notice - Nationwide
30th Jun 20175:02 pmRNSPublication of a Prospectus
2nd Jun 20173:11 pmRNSPublication of Final Terms
2nd Jun 20173:10 pmRNSPublication of Final Terms
2nd Jun 20173:07 pmRNSPublication of Final Terms
24th May 20176:13 pmRNSPublication of Suppl.Prospcts
23rd May 20177:00 amRNSPreliminary Results Announcement
18th May 20178:00 amRNSDoc re. Appointment of Non-Executive Director
3rd May 201712:01 pmRNSCCDS - Notification of Adjustment to PIR Cap
13th Apr 20173:46 pmRNSPublication of Final Terms
10th Apr 20178:48 amRNSStabilisation Notice - NWIDE 6YR EUR
3rd Apr 20172:41 pmRNSNotice of Updated Swap Agreements
21st Mar 201712:35 pmRNSPublication of Final Terms
23rd Feb 20172:49 pmRNSPublication of Final Terms
10th Feb 20171:14 pmRNSPublication of Interim Management Statement (Q3)
10th Feb 20177:00 amRNSInterim Management Statement
8th Feb 201710:04 amRNSPublication of Final Terms
23rd Jan 20171:41 pmRNSNotice of Amendments to Transaction Documents
18th Jan 201710:38 amRNSDoc re. Appointment of Non-Executive Director
19th Dec 20161:29 pmRNSNotice of Cancellation of Listing - PIBS
30th Nov 20167:15 amRNSNationwide's Response to the Stress Test Results
18th Nov 201612:41 pmRNSSupplement and Interim Results
18th Nov 20167:00 amRNSHalf-year Report
17th Oct 201612:30 pmRNSNotice by Issuer to the PIBS holders - Redemption
12th Sep 20164:03 pmRNSPublication of Final Terms
31st Aug 20166:00 pmRNSPublication of a Prospectus
12th Aug 20163:15 pmRNSPublication of Supplementary Prospectus
12th Aug 20167:00 amRNSInterim Management Statement
3rd Aug 20164:03 pmRNSPublication of a Prospectus
26th Jul 20164:58 pmRNSPublication of Final Terms
25th Jul 20163:39 pmRNSPublication of Final Terms

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.